MADISON SQUARE GARDEN SPORTS (MSGS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:MSGS - US55825T1034 - Common Stock
252.44 USD
+6.06 (+2.46%)
252.44 USD
0 (0%)
Taking everything into account, MSGS scores 2 out of 10 in our fundamental rating. MSGS was compared to 80 industry peers in the Entertainment industry. MSGS may be in some trouble as it scores bad on both profitability and health. MSGS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year MSGS has reported negative net income.
MSGS had a positive operating cash flow in the past year.
In multiple years MSGS reported negative net income over the last 5 years.
MSGS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
MSGS's Return On Assets of -1.56% is in line compared to the rest of the industry. MSGS outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.56% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)2.11%
ROA(5y)1.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
MSGS's Operating Margin has declined in the last couple of years.
The Gross Margin of MSGS (32.94%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MSGS has declined.
The Profit Margin and Operating Margin are not available for MSGS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.94% |
OM growth 3Y-48.58%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.62%
GM growth 5Y-3.48%
2. Health
2.1 Basic Checks
MSGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
MSGS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MSGS has about the same amount of shares outstanding.
The debt/assets ratio for MSGS has been reduced compared to a year ago.
2.2 Solvency
MSGS has an Altman-Z score of 2.19. This is not the best score and indicates that MSGS is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of MSGS (2.19) is better than 66.25% of its industry peers.
The Debt to FCF ratio of MSGS is 9.97, which is on the high side as it means it would take MSGS, 9.97 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MSGS (9.97) is better than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 9.97 | ||
| Altman-Z | 2.19 |
ROIC/WACCN/A
WACC9.78%
2.3 Liquidity
A Current Ratio of 0.39 indicates that MSGS may have some problems paying its short term obligations.
MSGS has a Current ratio of 0.39. This is amonst the worse of the industry: MSGS underperforms 82.50% of its industry peers.
MSGS has a Quick Ratio of 0.39. This is a bad value and indicates that MSGS is not financially healthy enough and could expect problems in meeting its short term obligations.
MSGS has a Quick ratio of 0.39. This is amonst the worse of the industry: MSGS underperforms 81.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.39 | ||
| Quick Ratio | 0.39 |
3. Growth
3.1 Past
MSGS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -133.68%.
Looking at the last year, MSGS shows a decrease in Revenue. The Revenue has decreased by -1.16% in the last year.
MSGS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.49% yearly.
EPS 1Y (TTM)-133.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.35%
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y8.16%
Revenue growth 5Y11.49%
Sales Q2Q%-25.99%
3.2 Future
The Earnings Per Share is expected to grow by 24.89% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.53% on average over the next years.
EPS Next Y82.04%
EPS Next 2Y32.53%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y2.83%
Revenue Next 3Y3.53%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
MSGS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MSGS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
61.25% of the companies in the same industry are more expensive than MSGS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 208.16 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as MSGS's earnings are expected to grow with 24.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.53%
EPS Next 3Y24.89%
5. Dividend
5.1 Amount
No dividends for MSGS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
252.44
+6.06 (+2.46%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners81.85%
Inst Owner ChangeN/A
Ins Owners2.36%
Ins Owner Change6.03%
Market Cap6.07B
Revenue(TTM)1.03B
Net Income(TTM)-23.70M
Analysts80
Price Target254.28 (0.73%)
Short Float %5.64%
Short Ratio5.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.03
Dividend Growth(5Y)N/A
DP-2.25%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.25%
Min EPS beat(2)39.44%
Max EPS beat(2)57.05%
EPS beat(4)2
Avg EPS beat(4)-32.18%
Min EPS beat(4)-141.27%
Max EPS beat(4)57.05%
EPS beat(8)5
Avg EPS beat(8)10.78%
EPS beat(12)7
Avg EPS beat(12)-4.95%
EPS beat(16)9
Avg EPS beat(16)16.9%
Revenue beat(2)1
Avg Revenue beat(2)11.52%
Min Revenue beat(2)-6.35%
Max Revenue beat(2)29.38%
Revenue beat(4)1
Avg Revenue beat(4)4.86%
Min Revenue beat(4)-6.35%
Max Revenue beat(4)29.38%
Revenue beat(8)4
Avg Revenue beat(8)8.83%
Revenue beat(12)8
Avg Revenue beat(12)12.75%
Revenue beat(16)10
Avg Revenue beat(16)14.87%
PT rev (1m)-0.99%
PT rev (3m)-0.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)200.51%
EPS NY rev (1m)76.86%
EPS NY rev (3m)60.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.99%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)-0.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 5.92 | ||
| P/FCF | 208.16 | ||
| P/OCF | 185.11 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.98
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)1.21
FCFY0.48%
OCF(TTM)1.36
OCFY0.54%
SpS42.62
BVpS-12.23
TBVpS-25.95
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.56% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.94% | ||
| FCFM | 2.85% |
ROA(3y)2.11%
ROA(5y)1.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.02%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-48.58%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.62%
GM growth 5Y-3.48%
F-Score3
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 9.97 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 111.89% | ||
| Cap/Sales | 0.35% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.39 | ||
| Quick Ratio | 0.39 | ||
| Altman-Z | 2.19 |
F-Score3
WACC9.78%
ROIC/WACCN/A
Cap/Depr(3y)91.68%
Cap/Depr(5y)60.4%
Cap/Sales(3y)0.32%
Cap/Sales(5y)0.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-133.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.35%
EPS Next Y82.04%
EPS Next 2Y32.53%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y8.16%
Revenue growth 5Y11.49%
Sales Q2Q%-25.99%
Revenue Next Year0.79%
Revenue Next 2Y2.83%
Revenue Next 3Y3.53%
Revenue Next 5YN/A
EBIT growth 1Y-102.85%
EBIT growth 3Y-44.39%
EBIT growth 5YN/A
EBIT Next Year-47.82%
EBIT Next 3Y-7.46%
EBIT Next 5YN/A
FCF growth 1Y-68.56%
FCF growth 3Y-20.81%
FCF growth 5YN/A
OCF growth 1Y-66.21%
OCF growth 3Y-19.88%
OCF growth 5Y91.04%
MADISON SQUARE GARDEN SPORTS / MSGS FAQ
What is the fundamental rating for MSGS stock?
ChartMill assigns a fundamental rating of 2 / 10 to MSGS.
What is the valuation status for MSGS stock?
ChartMill assigns a valuation rating of 2 / 10 to MADISON SQUARE GARDEN SPORTS (MSGS). This can be considered as Overvalued.
What is the profitability of MSGS stock?
MADISON SQUARE GARDEN SPORTS (MSGS) has a profitability rating of 2 / 10.
Can you provide the financial health for MSGS stock?
The financial health rating of MADISON SQUARE GARDEN SPORTS (MSGS) is 3 / 10.
Can you provide the dividend sustainability for MSGS stock?
The dividend rating of MADISON SQUARE GARDEN SPORTS (MSGS) is 0 / 10 and the dividend payout ratio is -2.25%.